Verastem Inc. is a clinical-stage biopharmaceutical company headquartered in Needham, Massachusetts, dedicated to developing and commercializing innovative therapies for patients battling cancer. With a particular focus on addressing unmet medical needs through its proprietary drug candidates, Verastem aims to enhance the quality of life and improve clinical outcomes for cancer patients. The company's robust pipeline includes targeted therapies designed to overcome treatment resistance and improve patient survivorship. As it advances its therapeutic candidates through clinical trials, Verastem is positioned to make significant contributions to oncology treatments and patient care.
Click "Analyze" to generate stock analysis
VSTM Price Trend and Signals
VSTM Option Volumes & Open Interests (aggregated)
VSTM Put Call Ratios and IV (aggregated)
VSTM Financials
2025-10-23Somewhat Bearishprice_signal
Monthly low detected.
2025-10-22Somewhat Bearishprice_signal
Monthly low detected.
2025-10-21Somewhat Bearishprice_signal
Monthly low detected.
2025-10-20Somewhat Bearishmacd_signal
Dead cross above zero detected.
2025-10-20Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.